/Companies

DEMECAN

7 known investors

Find your way into DEMECAN

Sign up to see every warm intro you have to DEMECAN

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the DEMECAN team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

DEMECAN produces and distributes medical cannabis products, including cannabis-containing medicines and extracts used to make capsules, which pharmacies can order directly. It provides information for patients and doctors on cannabis therapy and operates in Germany.

Investors · 7

Also in the syndicate · 5

btov's Private Investor NetworkENEXIS ABFutury GrowthFutury VentureMittelständische Beteiligungsgesellschaft Sachsen (MBG)

Funding

SEC filings, press & company announcements
  • Undisclosed amountSeries AOct 2019

    btov Partners (lead)

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Frequently asked questions

What does DEMECAN do?
DEMECAN produces and distributes medical cannabis products, including cannabis-containing medicines and extracts used to make capsules, which pharmacies can order directly. It provides information for patients and doctors on cannabis therapy and operates in Germany.
Who are DEMECAN's investors?
DEMECAN's investors include Futury Capital, TFO GmbH.